TR199700418A2 - Fluorlu D3 vitamini analoglari. - Google Patents

Fluorlu D3 vitamini analoglari.

Info

Publication number
TR199700418A2
TR199700418A2 TR97/00418A TR9700418A TR199700418A2 TR 199700418 A2 TR199700418 A2 TR 199700418A2 TR 97/00418 A TR97/00418 A TR 97/00418A TR 9700418 A TR9700418 A TR 9700418A TR 199700418 A2 TR199700418 A2 TR 199700418A2
Authority
TR
Turkey
Prior art keywords
fluoride
vitamin analogues
hydroxy
hydrogen
analogues
Prior art date
Application number
TR97/00418A
Other languages
English (en)
Other versions
TR199700418A3 (tr
Inventor
Michael Hennessy Bernard
Radoje Uskokovic Milan
Original Assignee
F. Hoffmann-La Roche & Co. Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche & Co. Ag. filed Critical F. Hoffmann-La Roche & Co. Ag.
Publication of TR199700418A3 publication Critical patent/TR199700418A3/tr
Publication of TR199700418A2 publication Critical patent/TR199700418A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Formülü havi bir bilesik olup burada R hidrojen, fluor veya hidroksidir, ve x de =CH2 dir veya R hidroksi oldugu zaman, x hidrojen veya =CH2 dir, ve bu bilesikler hiperproliferatif rahatsizliklarin neoplastik hastaliklarin ve yag salgilayan gland hastaliklarinin tedavisinde faydalidir.
TR97/00418A 1996-05-23 1997-05-23 Fluorlu D3 vitamini analoglari. TR199700418A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (2)

Publication Number Publication Date
TR199700418A3 TR199700418A3 (tr) 1997-12-21
TR199700418A2 true TR199700418A2 (tr) 1997-12-21

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/00418A TR199700418A2 (tr) 1996-05-23 1997-05-23 Fluorlu D3 vitamini analoglari.

Country Status (30)

Country Link
US (1) US5888994A (tr)
EP (1) EP0808831B1 (tr)
JP (1) JP2858571B2 (tr)
KR (1) KR100237523B1 (tr)
CN (1) CN1081184C (tr)
AR (1) AR007240A1 (tr)
AT (1) ATE195514T1 (tr)
AU (1) AU720098B2 (tr)
BR (1) BR9703373A (tr)
CA (1) CA2204478C (tr)
CO (1) CO4840512A1 (tr)
CZ (1) CZ157997A3 (tr)
DE (1) DE69702812T2 (tr)
DK (1) DK0808831T3 (tr)
ES (1) ES2150719T3 (tr)
GR (1) GR3034832T3 (tr)
HR (1) HRP970274A2 (tr)
HU (1) HUP9700927A3 (tr)
IL (1) IL120842A0 (tr)
MA (1) MA24345A1 (tr)
NO (1) NO971934L (tr)
NZ (1) NZ314838A (tr)
PL (1) PL320131A1 (tr)
PT (1) PT808831E (tr)
SG (1) SG50831A1 (tr)
TR (1) TR199700418A2 (tr)
TW (1) TW374762B (tr)
UY (1) UY24563A1 (tr)
YU (1) YU19997A (tr)
ZA (1) ZA974334B (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
EP0981514B1 (en) * 1997-05-16 2006-04-05 Woman & Infants Hospital 3-epi vitamin d2 compounds and uses thereof
EP0981523B1 (en) * 1997-05-16 2005-12-07 Woman & Infants Hospital Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof
DE69814109T2 (de) * 1997-09-08 2004-02-26 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
ES2904546T3 (es) 2006-02-03 2022-04-05 Opko Renal Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
PL2679228T3 (pl) 2006-06-21 2018-07-31 Opko Ireland Global Holdings, Ltd. Terapia z użyciem środka do uzupełniania witaminy D i środka do zastępowania hormonami witaminy D
CA2683628C (en) 2007-04-25 2018-03-06 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
DK2481400T3 (da) 2007-04-25 2014-09-29 Opko Ip Holdings Ii Inc Orale præparater med kontrolleret frigivelse omfattende en vitamin D-forbindelse og en voksagtig bærer
LT2552484T (lt) 2010-03-29 2020-04-27 Opko Ireland Global Holdings, Ltd. Būdai ir kompozicijos, skirti paratiroidų lygiams sumažinti
US8754067B2 (en) 2010-11-12 2014-06-17 Wisconsin Alumni Research Foundation 22-haloacetoxy-homopregnacalciferol analogs and their uses
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
EP3193925A2 (en) 2014-08-07 2017-07-26 OPKO Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin d
CN108883120A (zh) 2016-03-28 2018-11-23 欧普科爱尔兰环球控股有限公司 维生素d治疗方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
ATE141914T1 (de) * 1992-05-20 1996-09-15 Hoffmann La Roche Fluorierte analoge vitamins d3
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
TW267161B (tr) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
CO4840512A1 (es) 1999-09-27
NO971934L (no) 1997-11-24
US5888994A (en) 1999-03-30
NO971934D0 (no) 1997-04-25
ES2150719T3 (es) 2000-12-01
IL120842A0 (en) 1997-09-30
EP0808831A3 (en) 1999-02-03
DK0808831T3 (da) 2001-01-02
CA2204478A1 (en) 1997-11-23
TR199700418A3 (tr) 1997-12-21
UY24563A1 (es) 2000-12-29
MX9703776A (es) 1998-06-30
HRP970274A2 (en) 1998-04-30
DE69702812T2 (de) 2001-01-25
YU19997A (sh) 1999-07-28
SG50831A1 (en) 1998-07-20
CZ157997A3 (en) 1997-12-17
CN1081184C (zh) 2002-03-20
JPH1045712A (ja) 1998-02-17
AU2357297A (en) 1997-11-27
NZ314838A (en) 1998-01-26
ATE195514T1 (de) 2000-09-15
JP2858571B2 (ja) 1999-02-17
DE69702812D1 (de) 2000-09-21
AU720098B2 (en) 2000-05-25
PT808831E (pt) 2000-12-29
AR007240A1 (es) 1999-10-27
ZA974334B (en) 1997-11-24
KR100237523B1 (ko) 2000-01-15
CN1169425A (zh) 1998-01-07
EP0808831B1 (en) 2000-08-16
TW374762B (en) 1999-11-21
EP0808831A2 (en) 1997-11-26
KR970074763A (ko) 1997-12-10
MA24345A1 (fr) 1998-07-01
CA2204478C (en) 2006-11-21
GR3034832T3 (en) 2001-02-28
HU9700927D0 (en) 1997-07-28
HUP9700927A3 (en) 1999-07-28
BR9703373A (pt) 1998-09-15
HUP9700927A2 (hu) 1998-01-28
PL320131A1 (en) 1997-11-24

Similar Documents

Publication Publication Date Title
TR199700418A2 (tr) Fluorlu D3 vitamini analoglari.
CY1116988T1 (el) Βητα-l-2'-δεοξυ-νουκλεοζιτες για την θεραπεια ηπατιτιδας β
TR199700415A2 (tr) D3 vitamini analoglari.
UY24005A1 (es) Dentrifico antiseptico
DE69925133D1 (de) Pyrrolobenzodiazepine
DK0892638T3 (da) Liposombaseret, topisk vitamin D-præparat
DE69510940T2 (de) Pyrazolo und pyrrolopyridine
AU7619291A (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
ATE185066T1 (de) Lösung zur verwendung gegen den pilzbefall von nägeln
AU141695S (en) Respiratory mask
BR9913890B1 (pt) composição de cuidado oral e uso de um complexo de cobre ligado a maltol, hinoquitiol ou etilmatol.
ATE141914T1 (de) Fluorierte analoge vitamins d3
MXPA03001081A (es) Medicamento anti-inflamatorio.
NO934197D0 (no) Vitamin D-3-analoger
ATE233745T1 (de) Arzneistoffe
NO20005548L (no) Mykobakterieinhibitorer
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
TR199700219A2 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
ECSP972130A (es) Analogos de vitamina d3 - fluorinados
NO995132L (no) Fremgangsmåte for reduksjon av fibrinogen
AU133937S (en) A horse schooling aid
PE61999A1 (es) Compuestos de tetrahidropiridina